The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis
Hendrikse, C.S.E., Theelen, P.M.M., van der Ploeg, P., Westgeest, H.M., Boere, I.A., Thijs, A.M.J., Ottevanger, P.B., van de Stolpe, A., Lambrechts, S., Bekkers, R.L.M., Piek, J.M.J.
Published in Gynecologic oncology (01.04.2023)
Published in Gynecologic oncology (01.04.2023)
Get full text
Journal Article